Jounce Therapeutics, Inc. Current Ratio 2017-2022 | JNCE
Jounce Therapeutics, Inc. current ratio from 2017 to 2022. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2022-12-31 | $0.20B | $0.02B | 8.37 |
| 2022-09-30 | $0.14B | $0.02B | 6.42 |
| 2022-06-30 | $0.16B | $0.02B | 6.78 |
| 2022-03-31 | $0.17B | $0.02B | 9.87 |
| 2021-12-31 | $0.19B | $0.02B | 10.10 |
| 2021-09-30 | $0.23B | $0.02B | 12.67 |
| 2021-06-30 | $0.26B | $0.02B | 16.23 |
| 2021-03-31 | $0.27B | $0.01B | 20.66 |
| 2020-12-31 | $0.21B | $0.02B | 10.94 |
| 2020-09-30 | $0.11B | $0.02B | 6.60 |
| 2020-06-30 | $0.13B | $0.02B | 8.04 |
| 2020-03-31 | $0.15B | $0.01B | 10.66 |
| 2019-12-31 | $0.17B | $0.01B | 12.06 |
| 2019-09-30 | $0.18B | $0.01B | 13.61 |
| 2019-06-30 | $0.16B | $0.08B | 2.03 |
| 2019-03-31 | $0.17B | $0.08B | 2.24 |
| 2018-12-31 | $0.19B | $0.07B | 2.93 |
| 2018-09-30 | $0.21B | $0.07B | 3.07 |
| 2018-06-30 | $0.24B | $0.07B | 3.58 |
| 2018-03-31 | $0.26B | $0.07B | 3.63 |
| 2017-12-31 | $0.26B | $0.06B | 4.09 |
| 2017-09-30 | $0.26B | $0.06B | 4.13 |
| 2017-06-30 | $0.28B | $0.08B | 3.54 |
| 2017-03-31 | $0.27B | $0.09B | 3.04 |
| 2016-12-31 | $0.15B | $0.09B | 1.67 |
| 2016-09-30 | $0.00B | 0.00 | |
| 2016-06-30 | $0.00B | 0.00 | |
| 2016-03-31 | $0.00B | 0.00 | |
